SLIDESHOW: Top 10 Analyst Rated Healthcare Stocks
By ETF Channel Staff, updated Fri, December 1, 12:37 AM
This Slide: #2 of 10 |
#9: Bio-Techne Corp (NASDAQ:TECH)
Bio-Techne develops, manufactures and sells life science reagents, instruments and services for the research, diagnostics and bioprocessing markets. Co.'s Protein Sciences segment develops and manufactures biological reagents used in various aspects of life science research, diagnostics and cell and gene therapy. Co.'s Diagnostics and Genomics segment develops and manufactures diagnostic products, including controls, calibrators, and diagnostic assays for the regulated diagnostics market, exosome-based molecular diagnostic assays, tissue-based in-situ hybridization assays for spatial genomic and tissue biopsy analysis, and genetic and oncology kits for research and clinical applications. Open the TECH Page at ETF Channel »
![]()
![]() |
Open the ETF Channel TECH Page (in a new window) »
![]() Strong Buy (3.64 out of 4) 64th percentile
(ranked higher than approx. 64% of all stocks covered)
Based on data provided by Zacks Investment Research via Quandl.com ![]() |


![]() ![]() Get Dividend Alerts ![]() Get SEC Filing Alerts ![]() ![]() |
![]() Strong Buy (3.64 out of 4) 64th percentile
(ranked higher than approx. 64% of all stocks covered)
Analysts Forecast: TECH Price Target Based on data provided by Zacks Investment Research via Quandl.com ![]() |

![]() |